BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 18774954)

  • 21. Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.
    Hamadani M; Awan FT; Elder P; Lin TS; Porcu P; Benson DM; Blum KA; Devine SM
    Leuk Lymphoma; 2008 Oct; 49(10):1893-8. PubMed ID: 18949613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma].
    Ogura M
    Rinsho Ketsueki; 2008 Oct; 49(10):1434-50. PubMed ID: 18833928
    [No Abstract]   [Full Text] [Related]  

  • 24. Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.
    Costa LJ; Feldman AL; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Ansell SM
    Br J Haematol; 2008 Jul; 142(3):404-12. PubMed ID: 18492096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of hematopoietic cell transplantation for follicular non-Hodgkin's lymphoma.
    Laport GG
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):59-65. PubMed ID: 16399587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The curability of follicular lymphoma.
    Lunning M; Armitage JO
    Transfus Apher Sci; 2007 Aug; 37(1):31-5. PubMed ID: 17936072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.
    Leger C; Sabloff M; McDiarmid S; Bence-Bruckler I; Atkins H; Bredeson C; Zhang H; Huebsch L
    Ann Hematol; 2006 Oct; 85(10):723-9. PubMed ID: 16832675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen.
    Smith SD; Bolwell BJ; Rybicki LA; Brown S; Dean R; Kalaycio M; Sobecks R; Andresen S; Hsi ED; Pohlman B; Sweetenham JW
    Bone Marrow Transplant; 2007 Aug; 40(3):239-43. PubMed ID: 17530000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic stem cell transplantation for patients with advanced-stage follicular lymphoma.
    Numbenjapon T; Nademanee A
    J Med Assoc Thai; 2008 Oct; 91(10):1613-22. PubMed ID: 18972908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma: a study using patients as their own controls.
    Vignot S; Mounier N; Larghero J; Brice P; Quero L; de Bazelaire C; Ertault M; Brière J; Madelaine I; Gisselbrecht C
    Cancer; 2007 Jan; 109(1):60-7. PubMed ID: 17111421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
    Soussain C; Hoang-Xuan K; Taillandier L; Fourme E; Choquet S; Witz F; Casasnovas O; Dupriez B; Souleau B; Taksin AL; Gisselbrecht C; Jaccard A; Omuro A; Sanson M; Janvier M; Kolb B; Zini JM; Leblond V;
    J Clin Oncol; 2008 May; 26(15):2512-8. PubMed ID: 18413641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma.
    Hicks LK; Woods A; Buckstein R; Mangel J; Pennell N; Zhang L; Imrie K; Spaner D; Cheung MC; Boudreau A; Reis M; Crump M; Berinstein NL
    Bone Marrow Transplant; 2009 May; 43(9):701-8. PubMed ID: 19029963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation.
    Toze CL; Barnett MJ; Connors JM; Gascoyne RD; Voss NJ; Nantel SH; Nevill TJ; Shepherd JD; Sutherland HJ; Lavoie JC; Forrest DL; Song KW; Hogge DE
    Br J Haematol; 2004 Nov; 127(3):311-21. PubMed ID: 15491292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation.
    Costa LJ; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Ansell SM
    Bone Marrow Transplant; 2008 Apr; 41(8):715-20. PubMed ID: 18195687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
    Costa LJ; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Litzow MR; Ansell SM
    Br J Haematol; 2008 Oct; 143(2):268-73. PubMed ID: 18699848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma.
    Mortensen BK; Petersen SL; Kornblit B; Andersen PK; Braendstrup P; Andersen NS; Sengeløv H; Vindeløv L
    Eur J Haematol; 2012 Aug; 89(2):151-9. PubMed ID: 22574687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous stem-cell transplantation in patients with HIV-related lymphoma.
    Balsalobre P; Díez-Martín JL; Re A; Michieli M; Ribera JM; Canals C; Rosselet A; Conde E; Varela R; Cwynarski K; Gabriel I; Genet P; Guillerm G; Allione B; Ferrant A; Biron P; Espigado I; Serrano D; Sureda A
    J Clin Oncol; 2009 May; 27(13):2192-8. PubMed ID: 19332732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry.
    van Kampen RJ; Canals C; Schouten HC; Nagler A; Thomson KJ; Vernant JP; Buzyn A; Boogaerts MA; Luan JJ; Maury S; Milpied NJ; Jouet JP; Ossenkoppele GJ; Sureda A
    J Clin Oncol; 2011 Apr; 29(10):1342-8. PubMed ID: 21321299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
    Martín A; Conde E; Arnan M; Canales MA; Deben G; Sancho JM; Andreu R; Salar A; García-Sanchez P; Vázquez L; Nistal S; Requena MJ; Donato EM; González JA; León A; Ruiz C; Grande C; González-Barca E; Caballero MD;
    Haematologica; 2008 Dec; 93(12):1829-36. PubMed ID: 18945747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of diffuse large B-cell lymphoma subgroups in patients undergoing autologous SCT.
    Hallack Neto AE; Dulley FL; Coelho Siqueira SA; Pracchia LF; Belesso M; Saboya R; Sturaro D; Amigo-Filho JU; Mendrone Junior A; Chamone DA; Pereira J
    Bone Marrow Transplant; 2009 Feb; 43(4):323-5. PubMed ID: 18850022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.